Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma-Reference-Cited by-同舟云学术

Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma

Published:2018-01-23 Issue:1 Volume:10 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Heinemann Frauke G.,Tolkach Yuri,Deng Mario,Schmidt Doris,Perner Sven,Kristiansen Glen,Müller Stefan C.,Ellinger Jörg^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-018-0444-9.pdf

Reference40 articles.

1. Ljungberg B, Bensalah K, Bex A, et al. EAU Guidelines on Renal Cell Carcinoma, 2016, available from: http://uroweb.org/guideline/renal-cell-carcinoma/

2. Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 2009;103(11):1496–500. https://doi.org/10.1111/j.1464-410X.2008.08259 .

3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.

4. Sheth S, Scatarige JC, Horton KM, et al. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT. Radiographics. 2001;21:S237–54.

5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66. https://doi.org/10.1038/nrc1997 .

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology and epigenetic modifications definition;Genetics and Epigenetics of Genitourinary Diseases;2025

2. Liquid biopsy for renal cell carcinoma;Clinica Chimica Acta;2024-09

3. Liquid biopsy in renal cell carcinoma;The Oncologist;2024-08-26

4. Ultrasensitive upconverting nanoprobes for in situ imaging of drug-induced liver injury using miR-122 as the biomarker;Talanta;2024-07

5. Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis;Heliyon;2024-06